830741--4/14/2009--VIRTUALHEALTH_TECHNOLOGIES_INC.

related topics
{stock, price, share}
{stock, price, operating}
{customer, product, revenue}
{property, intellectual, protect}
{control, financial, internal}
{provision, law, control}
{personnel, key, retain}
{acquisition, growth, future}
{regulation, government, change}
We expect to incur losses in the future and may not achieve or maintain profitability. We have a limited operating history with which you can evaluate our current business model and prospects. If we cannot meet our future capital requirements, our business will suffe Our operating results may fluctuate, which may adversely affect our stock price. Our revenues for a particular period are difficult to predict, and a shortfall in revenues may harm our operating results. Product quality problems could lead to reduced revenues, gross margins, and net income. Our proprietary rights may prove difficult to enforce. We may be found to infringe on intellectual property rights of others. We rely on the availability of third-party licenses. Our operating results and future prospects could be materially harmed by uncertainties of regulation of the Healthcare market. Failure to retain and recruit key personnel would harm our ability to meet key objectives. Our stock price may continue to be volatile. Failure to manage our planned growth could harm our business. A few of our existing shareholders own a large percentage of our voting stock and will have a significant influence over matters requiring stockholder approval and could delay or prevent a change in control. Liquidity of our common stock. Sales of our common stock in the public market may lower our stock price and impair our ability to raise funds in future offerings. Our Articles and Bylaws may delay or prevent a potential takeover of

Full 10-K form ▸

related documents
1169567--4/15/2010--OXFORD_TECHNOLOGIES_INC
749251--2/28/2008--GARTNER_INC
26820--4/17/2006--PHOENIX_FOOTWEAR_GROUP_INC
1052489--3/31/2006--AMERICAN_BANK_NOTE_HOLOGRAPHICS_INC
901696--7/23/2007--MTI_TECHNOLOGY_CORP
790071--3/27/2008--ARISTOTLE_CORP
1083243--3/4/2009--ZAP_COM_CORP
5768--6/9/2006--AMERICAN_SCIENCE_&_ENGINEERING_INC
790071--3/26/2009--ARISTOTLE_CORP
854852--3/31/2008--Emrise_CORP
1030916--3/31/2010--OVM_INTERNATIONAL_HOLDING_CORP
790071--3/24/2006--ARISTOTLE_CORP
749251--2/20/2009--GARTNER_INC
352998--3/31/2010--IGI_INC
867840--9/26/2008--PRECISION_OPTICS_CORPORATION_INC
885307--11/3/2010--JEWETT_CAMERON_TRADING_CO_LTD
1005286--8/8/2008--LANDEC_CORP_\CA\
1005286--8/4/2009--LANDEC_CORP_\CA\
1047919--3/11/2009--AMBIENT_CORP_/NY
1005286--7/27/2007--LANDEC_CORP_\CA\
1444403--4/14/2010--GOLD_STANDARD_MINING_CORP.
1409565--9/25/2009--Puramed_Bioscience_Inc.
1419260--9/2/2010--Andina_Group_Inc.
1123695--4/14/2010--IMARX_THERAPEUTICS_INC
1398797--9/19/2008--Point.360
790071--4/2/2007--ARISTOTLE_CORP
887226--9/15/2008--PERCEPTRON_INC/MI
887226--9/28/2007--PERCEPTRON_INC/MI
867840--9/21/2010--PRECISION_OPTICS_CORPORATION_INC
867840--9/28/2009--PRECISION_OPTICS_CORPORATION_INC